Assignee profile:

FIBROCELL TECHNOLOGIES, INC.

City:

Exton, Pennsylvania

Country:

United States

Published Applications:

11

Last publication date:

2019-05-23

Patent Grants:

8

Last grant date:

2021-01-05

Top Inventors for applications by FIBROCELL TECHNOLOGIES, INC.

These are the the leading inventors for applications assigned to FIBROCELL TECHNOLOGIES, INC.:

Recent patent applications by FIBROCELL TECHNOLOGIES, INC.

FIBROCELL TECHNOLOGIES, INC. based in Exton, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2019-05-23 ✅ Patent 10,881,695 granted on 2021-01-05
US20190151368A1
Human necessities

Treatment of vocal cords with autologous dermal fibroblast formulation

#2 | 2018-12-06 ✅ Patent 10,900,020 granted on 2021-01-26
US20180346878A1
Chemistry; metallurgy

Methods for culturing minimally-passaged fibroblasts and uses thereof

#3 | 2017-02-09 ✅ Patent 10,098,914 granted on 2018-10-16
US20170035811A1
Human necessities

Treatment of vocal cords with autologous dermal fibroblast formulation

#4 | 2014-11-27 ✅ Patent 9,415,075 granted on 2016-08-16
US20140348801A1
Human necessities

Treatment of vocal cords with autologous dermal fibroblast formulation

#5 | 2014-11-13 ✅ Patent 9,902,937 granted on 2018-02-27
US20140335057A1
Chemistry; metallurgy

Methods for culturing minimally-passaged fibroblasts and uses thereof

#6 | 2014-04-10
US20140099383A1
Human necessities

Topical Dermal Formulations

#7 | 2014-03-13
US20140072611A1
Human necessities

Methods and Compositions for Treating Post-Cardial Infarction Damage

#8 | 2013-09-12
US20130236427A1
Human necessities

Topical Dermal Formulations and Methods of Personalized Treatment of Skin

#9 | 2013-08-29 ✅ Patent 8,765,121 granted on 2014-07-01
US20130224160A1
Human necessities

Treatment of vocal cords with autologous dermal fibroblast formulation

#10 | 2011-11-10 ✅ Patent 8,529,883 granted on 2013-09-10
US20110274665A1
Human necessities

Dosage unit formulations of autologous dermal fibroblasts

#11 | 2010-11-25 ✅ Patent 8,728,819 granted on 2014-05-20
US20100297088A1
Chemistry; metallurgy

Methods for culturing minimally-passaged fibroblasts and uses thereof

Also check out Fibrocell Technologies, Inc.'s (Exton, United States) applicant profile with 6 patent applications submitted.

AssigneeID:

36871 ⎘